Glipizide Extended-Release Tablets and Menactra

• Generic Name: glipizide
• Dosage Forms: n.a.
• Other Brand Names: Glucotrol, Glucotrol XL, Glipizide XL

• It is used to lower blood sugar in patients with high blood sugar (diabetes).

• Generic Name: meningococcal conjugate vaccine
• Dosage Forms: n.a.
• Other Brand Names: Menactra, Menveo

Menactra (meningococcal conjugate vaccine) is used to prevent infection caused by meningococcal bacteria.

Menactra works by exposing you to a small dose of the bacteria or a protein from the bacteria, which causes your body to develop immunity to the disease. Meningococcal conjugate vaccine contains four of the most common types of meningococcal bacteria (serogroups A, C, W, and Y).

Meningococcal disease is a serious infection caused by a bacteria. Meningococcal bacteria can infect the spinal cord and brain, causing meningitis that can be fatal. Meningococcal disease can also lead to permanent and disabling medical problems.

Meningococcal disease can spread from one person to another through small droplets of saliva that are expelled into the air when an infected person coughs or sneezes. The bacteria can also be passed through contact with objects the infected person has touched, such as a door handle or other surface. The bacteria can also be passed through kissing, or sharing a drinking glass or eating utensil with an infected person.

Meningococcal disease is more likely to occur in babies younger than 1 year, in young people ages 16 to 23 years, in anyone with a weak immune system, those without a functioning spleen, and in anyone exposed to an outbreak of the disease.

Menactra is used to prevent infection caused by meningococcal bacteria. The vaccine works by exposing you to a small dose of the bacteria or a protein from the bacteria, which causes your body to develop immunity to the disease. Menactra contains four of the most common types of meningococcal bacteria (serogroups A, C, W, and Y).

Menactra will not treat an active meningococcal infection that has already developed in the body.

Menactra is for use in children and adults between the ages of 9 months and 55 years old.

Like any vaccine, Menactra may not provide protection from disease in every person.